The EU Malaria Fund is a public-private partnership between the European Union, International Organizations, corporations, and organized civic society, providing a novel funding instrument to address market failures in infectious diseases with significant relevance to public health globally.Continue reading
Seven Facts about Plasmodium vivaxContinue reading
As of March 2019, Agustin Arasanz Duque has been named the new interim CEO of ITSL. Dr. Arasanz Duque is a senior consultant manager, with BS in Biology and Business Administration and Management from the University of Barcelona. Co-Founder of Hygeia Technologies S.L. and over 10 years of experience in preparing business plans, IP and regulatory affairs, and scouting new biomedical companies with early stage technologies.